Tag: Glaucoma


News

UTHSC’s Jablonski Wins $1.53M Award to Study Glaucoma Mechanisms and Develop Targeted Therapies

|

Glaucoma is the leading cause of irreversible blindness in the world and affects more than three million people in the United States each year. Currently, there is no cure for this crippling disease, only the option to treat one’s symptoms. Monica M. Jablonski, PhD, professor in the Department of Ophthalmology in the College of Medicine… Read More


News

Jablonski Selected as First User of UTHSC Innovation Lab Space

|

Monica M. Jablonski, PhD, professor in the Department of Ophthalmology in the College of Medicine at the University of Tennessee Health Science Center (UTHSC), has been selected as the first user of the UTHSC Innovation Lab space. The UTHSC Innovation Lab will allow Dr. Jablonski to further develop an ophthalmic microemulsion designed to combat the… Read More


News

The University of Tennessee Research Foundation Awards $15,000 Grants to Four UTHSC Faculty Members

|

Four faculty members at the University of Tennessee Health Science Center have received grants for $15,000 each from the University of Tennessee Research Foundation Maturation Funding Program. The program is designed to assist UT researchers to advance technologies that have the capacity for commercial success. The four grant recipients are Hassan Almoazen, PhD; Vanessa Morales-Tirado,… Read More


News

Vanessa Morales-Tirado of the Hamilton Eye Institute at UTHSC Receives $50,000 Grant for Ocular Immunology Research

|

At the Hamilton Eye Institute at the University of Tennessee Health Science Center (UTHSC), ophthalmology and immunology are joining forces to advance medicine. Vanessa Morales-Tirado, MS, PhD, assistant professor in the Department of Ophthalmology, and the Department of Microbiology, Immunology and Biochemistry in the College of Medicine at UTHSC, is using her background in immunology… Read More